Analysis: Lloyd Doggett's buy of JNJ (Johnson & Johnson)
Assessment: Low signal
Routine, automatic quarterly dividend reinvestment by a long-term buy-and-hold investor, showing no signal despite committee alignment.
- Member: Lloyd Doggett
- Party / state: D-TX
- Chamber: House
- Transaction: Buy
- Amount: $1,001 - $15,000
- Ticker: JNJ
- Company: Johnson & Johnson
- Trade date: 2026-06-09
- Disclosure date: 2026-07-06
- Disclosure lag: 27 days
Executive summary
The analyzed transaction is a Lloyd Doggett (D-TX, House) purchase of Johnson & Johnson (JNJ) on 2026-06-09 for $1,001-$15,000, explicitly described as automatic reinvestment of dividends, disclosed on 2026-07-06 (27-day lag). In the member’s provided trading history, JNJ appears as a recurring small-dollar purchase position (17 buys, 0 sells) alongside a small set of other recurring buy-only tickers. SEC insider filings in the window show director equity awards dated the same day as the trade and an EVP sale dated two days later (as reported in Form 4s).
Based on the user-provided dataset, the member’s activity shows repeated, small-range purchases across a narrow set of tickers over many years (7 tickers total; 224 trades; most commonly $1,001-$15,000), with no reported sales for the main recurring holdings (JNJ, IBM, PG, HD, KO, PPG). The analyzed JNJ transaction is explicitly labeled as an automatic dividend reinvestment, and there was additional nearby purchase activity in the portfolio (IBM on 2026-06-10; PPG on 2026-06-12; HD on 2026-06-18) suggesting ongoing periodic additions rather than a one-off directional change within the provided history. Within the SEC Form 4 window provided, three director award transactions (code A) were dated 2026-06-09 at $232.79, and an executive (EVP) reported option exercises and one sale (code S) dated 2026-06-11 at $241.15. Broader legislative/regulatory/news context could not be validated here because Congress.gov, Federal Register, Regulations.gov, USAspending, and external news search were not accessible in this environment.
Timeline
- 2026-04-14 — Johnson & Johnson filed Form 8-K (Items 2.02, 8.01, 9.01).
- 2026-04-28 — Johnson & Johnson filed Form 8-K (Items 5.07, 9.01).
- 2026-06-09 — Lloyd Doggett reported a purchase of JNJ ($1,001-$15,000), described as automatic reinvestment of dividends earned.
- 2026-06-09 — JNJ directors Eugene A. Woods, Daniel E Pinto, and Marillyn A Hewson reported grants/awards (Form 4 transaction code A) dated 2026-06-09 at $232.79 per share.
- 2026-06-10 — Same-day window portfolio activity: Lloyd Doggett purchase of IBM ($1,001-$15,000).
- 2026-06-11 — JNJ EVP Kathryn E. Wengel reported option exercises (code M) and an open market/private sale (code S) dated 2026-06-11 (sale price $241.15).
- 2026-06-12 — Additional Form 4 filing date in the window (accession 0000200406-26-000127).
- 2026-06-12 — Member trade in broader portfolio shortly after: PPG purchase ($1,001-$15,000) on 2026-06-12.
- 2026-06-18 — Member trade in broader portfolio shortly after: HD purchase ($1,001-$15,000) on 2026-06-18.
- 2026-07-06 — Disclosure filed for the 2026-06-09 JNJ transaction.
Independent analysis of public financial disclosures. Not financial or investment advice.